Fortitude Family Office’s Annovis Bio ANVS Stock Holding History

Fortitude Family Office’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-198	Closed	-$442	–	2277
2026 Q1	$442	Buy	+198	New	+$543	﹤0.01%	1771

Other funds holding ANVS

Sherry Group Mountain Home, Arkansas $102M AUM

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

DPW

DiNuzzo Private Wealth Beaver, Pennsylvania $1.01B AUM 16.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fortitude Family Office's ANVS Position: Q2 2026 in Review

Fortitude Family Office sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 198 shares — an estimated $442 sold.

Fortitude Family Office first reported a position in ANVS in Q1 2026 and held it in 1 quarter. The position peaked at $442 in Q1 2026. 7 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Fortitude Family Office reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
Fortitude Family Office sold 198 Annovis Bio shares in Q2 2026, an estimated $442.
Fortitude Family Office first reported a position in Annovis Bio in Q1 2026 and held it in 1 quarter.
Fortitude Family Office's Annovis Bio position peaked at $442 in Q1 2026.
7 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.